Literature DB >> 26680156

Prevalence of pre-sarcopenia and sarcopenia in Hong Kong Chinese geriatric patients with hip fracture and its correlation with different factors.

A Wh Ho1, M Ml Lee2, E Wc Chan2, H My Ng2, C W Lee2, W S Ng2, S H Wong1.   

Abstract

INTRODUCTION: Sarcopenia and osteoporosis are age-related declines in the quantity of muscle and bone, respectively. Both contribute in disability, fall, and hip fracture in the elderly. This study reported the prevalence of sarcopenia in Chinese geriatric patients with hip fracture, and the correlation between relative appendicular skeletal muscle mass index and other factors.
METHODS: This case series was conducted in Kowloon West Cluster Orthopaedic Rehabilitation Centre in Hong Kong. Data of all geriatric patients with primary hip fracture admitted to the above Centre from June to December 2014 were studied. Isometric grip strength, the maximal handgrip strength, was measured using a JAMAR hand dynamometer. Body composition including appendicular and whole-body lean body mass was measured using dual-energy X-ray absorptiometry. Pearson's correlation was used to examine the correlation between relative appendicular skeletal muscle mass index and other factors.
RESULTS: A total of 239 patients with a mean age of 82 years were included in the study. Stratifying patients as male or female, the mean (± standard deviation) hand grip strength was 20.6 ± 7.3 kg and 13.6 ± 4.5 kg, the mean relative appendicular skeletal muscle mass index was 5.72 ± 0.83 kg/m(2) and 4.87 ± 0.83 kg/m(2), and the mean hip bone mineral density was 0.696 ± 0.13 g/cm(2) and 0.622 ± 0.12 g/cm(2), respectively. The prevalence of sarcopenia based on relative appendicular skeletal muscle mass index and hand grip strength according to the Asian Working Group for Sarcopenia definition was 73.6% in males and 67.7% in females. According to the European Working Group on Sarcopenia definition, the prevalence of pre-sarcopenia was 20.8% in males and 12.4% in females. Relative appendicular skeletal muscle mass index was positively correlated with hand grip strength, body weight, hip bone mineral density, body mass index, and total fat mass in males; and hand grip strength, body weight, body height, body mass index, and total fat mass in females. Except for body height in females, all correlations were statistically significant.
CONCLUSION: The prevalence of sarcopenia was very high in geriatric hip fracture patients, and much higher than that in community-dwelling elderly population. Apart from the need to prescribe osteoporosis medicine, sarcopenia screening and treatment should be offered and is essential to reduce subsequent fall, subsequent fracture, fracture-related complications and economic burden to Hong Kong.

Entities:  

Keywords:  Aged; Hip fractures; Sarcopenia

Mesh:

Year:  2015        PMID: 26680156     DOI: 10.12809/hkmj154570

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  17 in total

1.  Sarcopenia: an unsolved problem after hip fracture.

Authors:  Jung-Wee Park; Hong-Seok Kim; Young-Kyun Lee; Jun-Il Yoo; Yangseon Choi; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  J Bone Miner Metab       Date:  2022-05-31       Impact factor: 2.626

2.  Recommendations on the post-acute management of the osteoporotic fracture - Patients with "very-high" Re-fracture risk.

Authors:  Ronald Man Yeung Wong; Wing-Hoi Cheung; Simon Kwoon Ho Chow; Raymond Wai Kit Ng; Wilson Li; Albert Yung-Chak Hsu; Kam Kwong Wong; Angela Wing-Hang Ho; Shing-Hing Choi; Christian Xinshuo Fang; Chun Fung Chan; Ka-Hei Leung; Kwok-Keung Chu; Timothy Chi Yui Kwok; Ming Hui Yang; Maoyi Tian; Sheung Wai Law
Journal:  J Orthop Translat       Date:  2022-10-10       Impact factor: 4.889

3.  Application of SDOC Cut Points for Low Muscle Strength for Recovery of Walking Speed After Hip Fracture.

Authors:  Denise L Orwig; Jay Magaziner; Roger A Fielding; Hao Zhu; Ellen F Binder; Peggy M Cawthon; Shalender Bhasin; Rosaly Correa-de-Araujo; Todd Manini; Sheena Patel; Michelle Shardell; Thomas G Travison
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

4.  Prevalence and clinical impact of sarcopenia in osteoporotic hip fracture: Single center retrospective cohort study.

Authors:  Won Chul Shin; Jae Hoon Jang; Han Eol Seo; Kuen Tak Suh; Nam Hoon Moon
Journal:  Acta Orthop Traumatol Turc       Date:  2020-01       Impact factor: 1.511

5.  Systematic review and meta-analysis of prevalence of sarcopenia in post acute inpatient rehabilitation.

Authors:  I Churilov; L Churilov; R J MacIsaac; E I Ekinci
Journal:  Osteoporos Int       Date:  2018-02-18       Impact factor: 4.507

6.  Comparing Longitudinal Sarcopenia Trends by Definitions Across Men and Women After Hip Fracture.

Authors:  Nancy Chiles Shaffer; Yi Huang; Danielle S Abraham; Yun-Ju Cheng; Wenxin Lu; Ann L Gruber-Baldini; Marc C Hochberg; Jack Guralnik; Jay Magaziner; Denise Orwig
Journal:  J Am Geriatr Soc       Date:  2020-04-01       Impact factor: 5.562

7.  Dietary Magnesium May Be Protective for Aging of Bone and Skeletal Muscle in Middle and Younger Older Age Men and Women: Cross-Sectional Findings from the UK Biobank Cohort.

Authors:  Ailsa A Welch; Jane Skinner; Mary Hickson
Journal:  Nutrients       Date:  2017-10-30       Impact factor: 5.717

8.  Does sarcopenia predict change in mobility after hip fracture? a multicenter observational study with one-year follow-up.

Authors:  Ole Martin Steihaug; Clara Gram Gjesdal; Bård Bogen; Målfrid Holen Kristoffersen; Gunhild Lien; Karl Ove Hufthammer; Anette Hylen Ranhoff
Journal:  BMC Geriatr       Date:  2018-03-05       Impact factor: 3.921

Review 9.  Orthogeriatric care: improving patient outcomes.

Authors:  Francisco José Tarazona-Santabalbina; Ángel Belenguer-Varea; Eduardo Rovira; David Cuesta-Peredó
Journal:  Clin Interv Aging       Date:  2016-06-24       Impact factor: 4.458

10.  Sarcopenia in patients with hip fracture: A multicenter cross-sectional study.

Authors:  Ole Martin Steihaug; Clara Gram Gjesdal; Bård Bogen; Målfrid Holen Kristoffersen; Gunhild Lien; Anette Hylen Ranhoff
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.